Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury



Status:Completed
Conditions:Hospital, Gastrointestinal
Therapuetic Areas:Gastroenterology, Other
Healthy:No
Age Range:18 - 80
Updated:4/2/2016
Start Date:September 2009
End Date:December 2013
Contact:Paul B Watkins, MD
Email:paul_watkins@med.unc.edu
Phone:919-226-3140

Use our guide to learn which trials are right for you!

Identification of New Biomarkers of Drug Induced Liver Injury

The purpose of this study is to try to develop new blood tests that may help doctors
identify if a drug is hurting a person's liver.

Our hypothesis is that there are liver-specific particles, called mRNA, that are
identifiable in a person's blood sample during liver injury caused by some drugs. The
purpose of this study is to try to develop new blood tests that may help doctors identify if
a drug is hurting a person's liver, perhaps early in the process before significant injury
or illness have occurred.

Inclusion Criteria:

- ALT > 200 IU/L at presentation to UNC Hospitals

- Drug induced liver injury considered likely by admitting medical staff
We found this trial at
1
site
Chapel Hill, North Carolina 27599
(919) 962-2211
Univ of North Carolina Carolina’s vibrant people and programs attest to the University’s long-standing place...
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials